Clinical trial
Tailored Antibiotic Susceptibility-guided Therapy Via Gastric Juice PCR for First-line H Pylori Eradication, a Prospective Randomized Controlled Trial
NCT04061447 is registered in ClinicalTrials.gov with Kaohsiung Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tailored Antibiotic Susceptibility-guided Therapy Via Gastric Juice PCR for First-line H Pylori Eradication, a Prospective Randomized Controlled Trial
- Lead sponsor
- Kaohsiung Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 5, 2016
- Completion date
- July 31, 2019
- Enrollment
- 182 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection